| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |